Answers are grounded in this paper and cite their sources.
The heteromeric amino acid transporter y⁺LAT1/CD98hc (SLC7A7/SLC3A2) mediates electroneutral exchange of cationic and neutral amino acids, with Na⁺ required for efficient transport of neutral substrates. Loss-of-function mutations cause Lysinuric Protein Intolerance (LPI), and emerging evidence highlights the physiological relevance of L-glutamine uptake in immune and bone cells. Here, we present the cryo-EM structure of human y⁺LAT1/CD98hc at 3.4 Å resolution in an outward-open conformation bound to L-glutamine, revealing a non-canonical substrate-binding pose involving Cys320 in TM8. Combining docking and molecular dynamics simulations, and functional assays, we identify a Na+-binding tetrad (Asn49–Ser131–Gly323–Ser327) that underlies Na⁺-dependent transport of neutral amino acids. By contrast, cationic substrates such as L-arginine occupy the same locus with their positively charged side chain, effectively replacing the role of Na⁺ and enabling Na⁺-independent exchange. Mutagenesis and kinetic analyses support this mechanism and reveal a key role for Glu128 during transitions toward inward-facing conformations, providing structural insight into the transport cycle. Collectively, these findings establish how y⁺LAT1 integrates Na⁺ and substrate recognition to mediate the selective exchange of neutral and cationic amino acids. Here, cryo-EM, functional and computational studies reveal how the lysinuric protein intolerance transporter y⁺LAT1/CD98hc integrates Na⁺ and substrate recognition to mediate selective exchange of neutral and cationic amino acids.
No takes yet. Share an insight, caveat, or question.
Alarcón et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: